Replimune (REPL) Accumulated Expenses (2018 - 2026)

Replimune has reported Accumulated Expenses for 9 years, with the latest figure at $47.5 million in Q1 2026.

• Quarterly Accumulated Expenses rose 3.48% year-over-year to $47.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $47.5 million (up 3.48% YoY) and the FY2026 annual result came in at $47.5 million, up 3.48% from the prior year.
• Accumulated Expenses improved to $47.5 million in Q1 2026 per REPL's latest filing, from $40.4 million in the prior quarter.
• Over five years, Accumulated Expenses peaked at $47.5 million in Q1 2026 and troughed at $12.2 million in Q2 2022.
• A 5-year average of $30.6 million and a median of $31.4 million in 2024 frame the typical range for Accumulated Expenses.
• The sharpest annual moves came in 2023 and 2024: Accumulated Expenses surged 98.58% in 2023, then decreased 0.72% in 2024.
• Over 5 years, Accumulated Expenses stood at $19.2 million in 2022, then surged by 61.22% to $30.9 million in 2023, then advanced by 19.02% to $36.8 million in 2024, then grew by 9.81% to $40.4 million in 2025, then advanced by 17.72% to $47.5 million in 2026.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $47.5 million, $40.4 million, and $42.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.